Located at the heart of the London Cancer Hub, the Innovation Gateway offers high-quality laboratory, office and collaboration space for a range of companies working in the life sciences.
The lead partners in The London Cancer Hub, The Institute of Cancer Research, London, and the London Borough of Sutton, are aiming to attract a wide variety of companies in the life sciences relating to oncology including drug discovery and development
The site is already home to The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust, which together are ranked in the world’s top four centres for cancer research and treatment., immuno-oncology, Big Data and AI, microscopy, imaging and medical physics.
Occupiers of the Innovation Gateway will have opportunities to collaborate with world-leading academic researchers at the ICR, as well as access some of its state-of-the-art equipment and facilities – including in the new £75m Centre for Cancer Drug Discovery, which is only metres from the new incubator space.
The Innovation Gateway contains around 6,300 square feet of space, with around 3,500 square metres set to be wet laboratories.
Facilities will include up to seven individual Category 2 labs, plus shared lab space, up to four office spaces for specific companies, a large hot desking area, break-out meeting rooms and kitchen facilities. Additionally, subject to individual agreements with the ICR, occupiers will have access to a range of cutting-edge technologies, services and facilities.
A major draw for companies will be the opportunity to collaborate with world-class scientists and clinicians at the ICR – including at the new Centre for Cancer Drug Discovery next door.
The ICR is already one of the top academic institutes in the world in partnering with industry, currently working with more than 100 companies: from small biotech and medtech firms, to Big Pharma.
World-renowned for its excellence in drug discovery, the ICR discovers more new cancer drugs than any other academic centre globally. Since 2005, it has discovered 20 drug candidates and taken 11 of them into clinical trials.
At the Sutton site, the ICR and The Royal Marsden together run one of the world’s largest and most successful centres for phase I clinical trials – leading around 50 early-stage trials of novel drugs at any one time, with many in collaboration with industry.
Get in touch to find out more about the opportunities at the Innovation Gateway.